T. Anh Wartel MD

Dr. T. Anh Wartel has 20 years of experience in epidemiological studies, clinical research from phase I to phase IV studies, and CTD development. She earned her MD at the Paris XII Medical School, France, and completed a post-graduate diploma in Public Health from the University of Liverpool, UK. She has extensive experience in the fields of epidemiological and clinical research within both academia and the pharmaceutical industry during her 15 year-long careers with Sanofi Pasteur before joining IVI in 2018. After having started her research career as a co-investigator in drugs and therapeutic vaccine trials in HIV-infected patients at the French National Agency of Research on HIV/AIDS (ANRS) at Kremlin Bicetre University Hospital in Paris, she then joined Sanofi Pasteur in 2003.

Her responsibilities grew over the course of 15 years to include Epidemiology and Clinical R&D activities (e.g., Japanese encephalitis, Pneumococcal Disease, Dengue Disease); Medical Affairs activities as the Regional Medical Expert for enteric, endemic, and travelers vaccines (e.g., rabies, cholera, typhoid fever, hepatitis A, yellow fever, dengue, Japanese encephalitis vaccines); and Country Medical Head for Vietnam and Cambodia. She joined IVI in September of 2018 as the Head of Clinical Development and Regulatory.